Literature DB >> 12207342

Targeting of CD45 protein tyrosine phosphatase activity to lipid microdomains on the T cell surface inhibits TCR signaling.

Xiao He1, Terry A Woodford-Thomas, Kenneth G Johnson, Dulari D Shah, Matthew L Thomas.   

Abstract

CD45, a transmembrane protein tyrosine phosphatase (PTP), can either positively or negatively regulate Src-family protein tyrosine kinase (PTK) activity in vivo. It is proposed that TCR-initiated signaling requires the segregation of PTP activities from the engaged TCR, based upon the differential membrane compartmentalization on the T cell surface. To test the importance of CD45 exclusion from lipid microdomains for proper TCR signaling, a chimeric molecule was generated by fusing the CD45 cytoplasmic region, which contains the PTP domains, to the amino-terminal 12 amino acids of Lck, which target Lck to lipid microdomains. Using 3A9 T lymphocyte hybridoma (3A9H) cells whose TCR recognizes hen egg-white lysozyme (HEL), Lck-CD45 expression resulted in its targeting to lipid microdomains. The 3A9H cells expressing Lck-CD45 were reduced in their responses to HEL or co-cross-linking of CD3 and CD4, as assessed by IL-2 production and Ca(2+) mobilization. Src-family PTK activity associated with lipid microdomains was also decreased. These results suggest that the segregation of CD45 from proximal TCR signaling components is necessary for TCR signaling and that the targeting of CD45 PTP activity to lipid microdomains on the T cell surface results in decreased sensitivity of TCR-mediated signaling.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12207342     DOI: 10.1002/1521-4141(200209)32:9<2578::AID-IMMU2578>3.0.CO;2-3

Source DB:  PubMed          Journal:  Eur J Immunol        ISSN: 0014-2980            Impact factor:   5.532


  9 in total

Review 1.  Positive and negative regulation of T-cell activation through kinases and phosphatases.

Authors:  Tomas Mustelin; Kjetil Taskén
Journal:  Biochem J       Date:  2003-04-01       Impact factor: 3.857

Review 2.  CD45: all is not yet crystal clear.

Authors:  Nick Holmes
Journal:  Immunology       Date:  2006-02       Impact factor: 7.397

3.  Lowering glycosphingolipid levels in CD4+ T cells attenuates T cell receptor signaling, cytokine production, and differentiation to the Th17 lineage.

Authors:  Yunxiang Zhu; Nathan Gumlaw; Jozsef Karman; Hongmei Zhao; Jinhua Zhang; Ji-Lei Jiang; Pete Maniatis; Andrea Edling; Wei-Lien Chuang; Craig Siegel; James A Shayman; Johanne Kaplan; Canwen Jiang; Seng H Cheng
Journal:  J Biol Chem       Date:  2011-03-14       Impact factor: 5.157

Review 4.  Regulation of T-cell receptor signalling by membrane microdomains.

Authors:  Tahir M Razzaq; Patricia Ozegbe; Elizabeth C Jury; Phupinder Sembi; Nathan M Blackwell; Panagiotis S Kabouridis
Journal:  Immunology       Date:  2004-12       Impact factor: 7.397

5.  Protein phosphatase 2A is a negative regulator of IL-2 production in patients with systemic lupus erythematosus.

Authors:  Christina G Katsiari; Vasileios C Kyttaris; Yuang-Taung Juang; George C Tsokos
Journal:  J Clin Invest       Date:  2005-10-13       Impact factor: 14.808

Review 6.  T-cell growth, cell surface organization, and the galectin-glycoprotein lattice.

Authors:  Ani Grigorian; Sevan Torossian; Michael Demetriou
Journal:  Immunol Rev       Date:  2009-07       Impact factor: 12.988

Review 7.  CD45, CD148, and Lyp/Pep: critical phosphatases regulating Src family kinase signaling networks in immune cells.

Authors:  Michelle L Hermiston; Julie Zikherman; Jing W Zhu
Journal:  Immunol Rev       Date:  2009-03       Impact factor: 12.988

8.  Activation of c-Src and Fyn kinases by protein-tyrosine phosphatase RPTPalpha is substrate-specific and compatible with lipid raft localization.

Authors:  Nathalie Vacaresse; Bente Møller; E Michael Danielsen; Masato Okada; Jan Sap
Journal:  J Biol Chem       Date:  2008-10-23       Impact factor: 5.157

9.  Biophysical mechanism of T-cell receptor triggering in a reconstituted system.

Authors:  John R James; Ronald D Vale
Journal:  Nature       Date:  2012-07-05       Impact factor: 49.962

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.